NEW YORK, July 1 (GenomeWeb News) - Interleukin Genetics of Waltham, Mass., today announced a research agreement with Access Business Group, a subsidiary of Alticor, to conduct research into the development of a test to identify individuals with specific genetic variations that affect how people gain and maintain weight.
The agreement also includes the development of nutritional products targeting those who are overweight, but not obese.
Interleukin is eligible to receive up to $1.9 million in additional research funding over 12 months, beginning on July 1, 2004 contingent on performance milestones.
The project is based on the perilipin gene licensed by Interleukin, the company said in a statement.